| Literature DB >> 30853213 |
Matthew Simon1, Michael Van Meter1, Julia Ablaeva1, Zhonghe Ke1, Raul S Gonzalez2, Taketo Taguchi1, Marco De Cecco3, Katerina I Leonova4, Valeria Kogan3, Stephen L Helfand5, Nicola Neretti5, Asael Roichman6, Haim Y Cohen6, Margarita V Meer7, Vadim N Gladyshev7, Marina P Antoch8, Andrei V Gudkov4, John M Sedivy5, Andrei Seluanov9, Vera Gorbunova10.
Abstract
Mice deficient for SIRT6 exhibit a severely shortened lifespan, growth retardation, and highly elevated LINE1 (L1) activity. Here we report that SIRT6-deficient cells and tissues accumulate abundant cytoplasmic L1 cDNA, which triggers strong type I interferon response via activation of cGAS. Remarkably, nucleoside reverse-transcriptase inhibitors (NRTIs), which inhibit L1 retrotransposition, significantly improved health and lifespan of SIRT6 knockout mice and completely rescued type I interferon response. In tissue culture, inhibition of L1 with siRNA or NRTIs abrogated type I interferon response, in addition to a significant reduction of DNA damage markers. These results indicate that L1 activation contributes to the pathologies of SIRT6 knockout mice. Similarly, L1 transcription, cytoplasmic cDNA copy number, and type I interferons were elevated in the wild-type aged mice. As sterile inflammation is a hallmark of aging, we propose that modulating L1 activity may be an important strategy for attenuating age-related pathologies.Entities:
Keywords: SIRT6; aging; longevity; nucleotide reverse-transcriptase inhibitors; retrotransposition
Mesh:
Substances:
Year: 2019 PMID: 30853213 PMCID: PMC6449196 DOI: 10.1016/j.cmet.2019.02.014
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287